Latest news with #QueenMaryUniversityofLondon
Time of India
2 days ago
- Entertainment
- Time of India
Who is Vijay Mallya's daughter-in-law, Jasmine, married to his son Sidhartha? Her education, career
Vijay Mallya's daughter-in-law, Jasmine, came into the spotlight last year after marrying his only son, Sidhartha Mallya, in June. While the ceremony received attention for its grandeur and celebrity guest list, many have been curious to know more about Jasmine herself—her background, education and career path. Life in the United States Jasmine has spent most of her life in the United States. She is known for her love of nature, animals, and travel, which is prominently reflected in her social media presence. Her Instagram feed is filled with glimpses of outdoor adventures, scenic destinations, and candid moments with her two pet dogs—a golden retriever and a husky. Though her formal educational qualifications have not been publicly disclosed, Jasmine's initiatives indicate an awareness of global and humanitarian issues. Career and Philanthropy Jasmine is recognized not just as a public figure by association, but as an independent voice in social advocacy. She supports the Ceasefire Centre for Civilian Rights, which focuses on protecting civilian rights and promoting accountability in conflict-affected regions. Additionally, Jasmine contributes to abortion funds in the United States, particularly in areas where access to reproductive healthcare is restricted. While Jasmine does not appear to be engaged in a traditional corporate career, her philanthropic activity and social engagement reflect a profile that aligns more with advocacy and awareness. Jasmine's relationship with Sidhartha Mallya began years before their 2024 marriage. The two reportedly got engaged in late 2023 after dating for about a year. One quirky detail that has gained fan interest is their shared love for the Harry Potter series—so much so that they even have matching themed tattoos. Sidhartha Mallya: From Business Legacy to Entertainment Born in Los Angeles, Sidhartha spent his early years between the UAE and England. He pursued his education at prestigious institutions like Wellington College, Queen Mary University of London, and the Royal Central School of Speech and Drama. He later chose a path in modelling and acting, establishing a career in entertainment, separate from his father's business legacy. Known previously for his relationship with Bollywood actor Deepika Padukone, Sidhartha's personal life has often been in the spotlight.
Economic Times
2 days ago
- Entertainment
- Economic Times
Who is Vijay Mallya's daughter-in-law, Jasmine, married to his son Sidhartha? Her education, career
Life in the United States Career and Philanthropy Sidhartha Mallya: From Business Legacy to Entertainment Vijay Mallya's daughter-in-law, Jasmine, came into the spotlight last year after marrying his only son, Sidhartha Mallya, in June. While the ceremony received attention for its grandeur and celebrity guest list, many have been curious to know more about Jasmine herself—her background, education and career has spent most of her life in the United States. She is known for her love of nature, animals, and travel, which is prominently reflected in her social media presence. Her Instagram feed is filled with glimpses of outdoor adventures, scenic destinations, and candid moments with her two pet dogs—a golden retriever and a her formal educational qualifications have not been publicly disclosed, Jasmine's initiatives indicate an awareness of global and humanitarian is recognized not just as a public figure by association, but as an independent voice in social advocacy. She supports the Ceasefire Centre for Civilian Rights, which focuses on protecting civilian rights and promoting accountability in conflict-affected Jasmine contributes to abortion funds in the United States, particularly in areas where access to reproductive healthcare is Jasmine does not appear to be engaged in a traditional corporate career, her philanthropic activity and social engagement reflect a profile that aligns more with advocacy and relationship with Sidhartha Mallya began years before their 2024 marriage. The two reportedly got engaged in late 2023 after dating for about a year. One quirky detail that has gained fan interest is their shared love for the Harry Potter series—so much so that they even have matching themed in Los Angeles, Sidhartha spent his early years between the UAE and England. He pursued his education at prestigious institutions like Wellington College, Queen Mary University of London, and the Royal Central School of Speech and Drama. He later chose a path in modelling and acting, establishing a career in entertainment, separate from his father's business previously for his relationship with Bollywood actor Deepika Padukone, Sidhartha's personal life has often been in the spotlight.
The Hindu
4 days ago
- Science
- The Hindu
Rediscovery of the Losgna genus in India: a new species of parasitic wasp discovered in Chandigarh, named - ‘Losgna Occidentalis'
At a time when habitat loss and climate change threaten countless species, the discovery of a new species of parasitic wasp - named 'Losgna Occidentalis' from Chandigarh has drawn attention to the unexplored richness of India's biodiversity. A recent study published in Zootaxa, a peer-reviewed scientific journal for animal taxonomists, titled - 'Rediscovery and description of a new species of Losgna (Cameron 1903): reviving a forgotten ichneumonid genus (Darwin wasps) in India' - points out the rediscovery of the Losgna genus in India, after close to six decades, and describes 'a new species collected from an urban dry scrub forest in Chandigarh.' 'The solitary Losgna (wasp) specimen was collected from a windowsill in Chandigarh, during winter 2023–24. This locality marks the first time any new insect species has been formally described from Chandigarh. The specimen belongs to a parasitic wasp (family Ichneumonidae), a group known for laying eggs inside or on other arthropod hosts. Prior to this discovery, Losgna had not been recorded in India since Heinrich's 1965 monograph. No records, specimens or published literature on Losgna existed in any Indian institution after 1965. It appeared that the genus had vanished entirely from its once‐documented range in northeast India until we found this new specimen in Chandigarh,' Karmannye Chaudhary, who led the study, a researcher in bird ecology and insect taxonomy at the Queen Mary University of London, told The Hindu. 'We named the new species 'Losgna occidentalis' because it represents the westernmost known occurrence of the genus: prior records came exclusively from tropical forests of eastern India and adjacent regions of Southeast Asia. 'Occidentalis' signifies this western extension,' he said. Pointing out that the only existing specimens of any Losgna species are those preserved at the Natural History Museum, London, The Hope Collection, Oxford University and the Zoologische Staatssammlung München (ZSM), Munich - all dating from the British era, Mr. Chaudhary said, 'No other collections -Indian or international - were found to hold Losgna material between 1965 and our study.' 'As a researcher of Hymenoptera, I'm thrilled by the discovery of Losgna occidentalis. It highlights the importance of solid taxonomic work and shows how young people, and even citizens, can find new species in their own backyards. This project also exemplifies valuable international collaboration between institutions like the NHM and Oxford, which is vital given how underfunded and poorly coordinated taxonomy has become. Hymenoptera are crucial as pollinators and biological control agents, so identifying and describing new species is essential for understanding and conserving our ecosystems. I hope this discovery inspires others to explore local habitats, collect specimens responsibly, and collaborate across borders to document India's hidden biodiversity,' said Ritesh Kumar Gautam, scientist at Wildlife Institute of India, Dehradun, Uttarakhand.
Miami Herald
13-05-2025
- Health
- Miami Herald
Blood testing could spot cancer early, study says
May 9 (UPI) -- Blood tests could catch as many as half of cancers at an earlier, more treatable stage, a new study says. If conducted every year or every other year, the multi-cancer early detection blood test could help more people survive cancer, researchers reported Thursday in BMJ Open. "Both annual and biennial MCED screening intervals have the potential to avert deaths associated with late-stage cancers when used in addition to current guideline-based cancer screening," concluded a research team led by Peter Sasieni, a professor of cancer epidemiology with Queen Mary University of London. The blood test looks for many different cancer-specific signals, including DNA fragments shed by tumors, researchers said. Only a few screenings today can reliably detect cancer among those at high risk, including tests for breast, colon, cervical and lung cancers, researchers said. Blood testing offers an opportunity to detect dozens of different cancer types by looking for cancer markers in people's bloodstream. To estimate the usefulness of blood testing in regular cancer screening, researchers analyzed data from an earlier clinical trial that used the blood test to help diagnose cancer. The analysis showed that blood testing improved early diagnosis for a wide variety of cancers. Compared with standard cancer screening, annual blood testing was associated with 49% fewer late-stage cancer diagnoses and 21% fewer deaths within five years, results show. Blood testing every other year resulted in 39% fewer late-stage diagnoses and 17% fewer deaths within five years, researchers added. Among people diagnosed with an aggressive, fast-growing cancer, blood tests could avert 14% to 21% deaths within five years, results show. "Based on the performance characteristics from a case control study, both annual and biennial screening with an MCED test have the potential to intercept 31% to 49% of cancers at stage 1-2 that would otherwise present at stage 3-4," researchers estimate. "Of these, approximately equal numbers would be detected at stage 1 and at stage 2," they added. These estimates assume complete compliance with screening schedules and follow-up testing, which is optimistic, researchers noted. They also assume that more early-stage diagnoses will automatically reduce death rates. "The optimal choice of screening interval will depend on assessments of real-world cancer survival and the costs of confirmatory testing after MCED screening," researchers said. More information The Cleveland Clinic has more on blood tests for cancer. Copyright © 2025 HealthDay. All rights reserved. Copyright 2025 UPI News Corporation. All Rights Reserved.
Yahoo
09-05-2025
- Health
- Yahoo
Blood testing could spot cancer early, study says
May 9 (UPI) -- Blood tests could catch as many as half of cancers at an earlier, more treatable stage, a new study says. If conducted every year or every other year, the multi-cancer early detection blood test could help more people survive cancer, researchers reported Thursday in BMJ Open. "Both annual and biennial MCED screening intervals have the potential to avert deaths associated with late-stage cancers when used in addition to current guideline-based cancer screening," concluded a research team led by Peter Sasieni, a professor of cancer epidemiology with Queen Mary University of London. The blood test looks for many different cancer-specific signals, including DNA fragments shed by tumors, researchers said. Only a few screenings today can reliably detect cancer among those at high risk, including tests for breast, colon, cervical and lung cancers, researchers said. Blood testing offers an opportunity to detect dozens of different cancer types by looking for cancer markers in people's bloodstream. To estimate the usefulness of blood testing in regular cancer screening, researchers analyzed data from an earlier clinical trial that used the blood test to help diagnose cancer. The analysis showed that blood testing improved early diagnosis for a wide variety of cancers. Compared with standard cancer screening, annual blood testing was associated with 49% fewer late-stage cancer diagnoses and 21% fewer deaths within five years, results show. Blood testing every other year resulted in 39% fewer late-stage diagnoses and 17% fewer deaths within five years, researchers added. Among people diagnosed with an aggressive, fast-growing cancer, blood tests could avert 14% to 21% deaths within five years, results show. "Based on the performance characteristics from a case control study, both annual and biennial screening with an MCED test have the potential to intercept 31% to 49% of cancers at stage 1-2 that would otherwise present at stage 3-4," researchers estimate. "Of these, approximately equal numbers would be detected at stage 1 and at stage 2," they added. These estimates assume complete compliance with screening schedules and follow-up testing, which is optimistic, researchers noted. They also assume that more early-stage diagnoses will automatically reduce death rates. "The optimal choice of screening interval will depend on assessments of real-world cancer survival and the costs of confirmatory testing after MCED screening," researchers said. More information The Cleveland Clinic has more on blood tests for cancer. Copyright © 2025 HealthDay. All rights reserved.
